Testing a new drug in healthy people and those with heart condition
Part of Heart & circulation clinical trials.
This trial tests a new medicine called UDP-003 in two groups: healthy volunteers and people who had a heart event (acute coronary syndrome) at least a year ago. The goal is to see if the drug is safe and how the body handles it, which could lead to better treatments for heart disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult between 18 and 65 years old (for healthy volunteers) or 40 to 79 years old (if you have had a heart event).
- For healthy volunteers: your body mass index (BMI) must be between 18 and 32, and your weight between 110 and 264 pounds.
- If you smoke, you must not have used any nicotine products for at least two weeks before the study starts.
- You should be generally healthy with no major medical issues, and your kidney and liver tests must be within normal limits.
- If you have had a heart event (acute coronary syndrome), it must have been at least 12 months ago, and you should be on stable heart medications for at least 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.
This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
This trial tests a new medicine (CKD-339) in healthy people to see how the body processes it and if it is safe. It is an early-stage study that could help develop a treatment for conditions like high blood pressure or heart problems.
This trial tests two forms of a new medicine to see how safe they are and how the body handles them. It is for healthy adults aged 19 to 64, and participation helps gather important early information before the drug is studied in patients.
This trial tests a new medication, AZD0780, to see if it helps prevent major cardiovascular events like heart attacks or strokes in people who already have heart or blood vessel disease, or are at high risk for a first event. It might be a good fit if your cholesterol isn't well-controlled despite current treatments.
This study tests a new drug called CG-0416 in healthy volunteers to see how safe it is and how the body handles it. The drug is given as a single dose or repeated doses, and researchers will monitor your health and cholesterol levels.
Hear when a new Atherosclerotic Cardiovascular Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.